These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6635442)

  • 41. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
    Drugeon HB; Dellamonica P; Caillon J
    Pathol Biol (Paris); 1987 May; 35(5):495-500. PubMed ID: 3302851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of pH on the morphology of Staphylococcus aureus.
    Mirza J; Kim Y; Lorian V
    Drugs Exp Clin Res; 1985; 11(3):149-53. PubMed ID: 3915285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Activity of indolicidin, alone or together with oxacillin, against Staphylococcus aureus and S. epidermidis].
    Walencka E; Sadowska B; Wieckowska-Szakiel M; Rózalska B
    Med Dosw Mikrobiol; 2008; 60(3):191-6. PubMed ID: 19143172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus: a high initial inoculum of 1 x 108 cfu/ml for in vivo test.
    Inoue M; Suzuki T; Fujita Y; Oda M; Matsumoto N; Iijima J; Yamase T
    Biomed Pharmacother; 2006 Jun; 60(5):220-6. PubMed ID: 16757145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.
    Liu H; Buescher G; Lewis N; Snyder S; Jungkind D
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):717-24. PubMed ID: 2261916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Havel M; Georgopoulos A
    Infection; 1984; 12(4):293-5. PubMed ID: 6092279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of ceftazidime in combination with other antibiotics.
    Simon C; Littschwager G
    Infection; 1985; 13(4):184-9. PubMed ID: 3930407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
    Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
    Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Label-free quantitative proteomics analysis of antibiotic response in Staphylococcus aureus to oxacillin.
    Liu X; Hu Y; Pai PJ; Chen D; Lam H
    J Proteome Res; 2014 Mar; 13(3):1223-33. PubMed ID: 24156611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of clinical isolates of Staphylococcus aureus to killing by oxacillin.
    Best GK; Koval AV; Best NH
    Can J Microbiol; 1975 Nov; 21(11):1692-7. PubMed ID: 1201514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
    Bakar NS; Zin NM; Basri DF
    Pak J Pharm Sci; 2012 Jul; 25(3):633-8. PubMed ID: 22713953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.
    Croes S; Beisser PS; Terporten PH; Neef C; Deurenberg RH; Stobberingh EE
    Clin Microbiol Infect; 2010 Jul; 16(7):979-85. PubMed ID: 20880412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sub-inhibitory concentrations of oxacillin modify the expression of agr locus in Staphylococcus aureus clinical strains belonging to different clonal complexes.
    Viedma E; Pérez-Montarelo D; Villa J; Muñoz-Gallego I; Larrosa N; Fernández-Hidalgo N; Gavaldà J; Almirante B; Chaves F
    BMC Infect Dis; 2018 Apr; 18(1):177. PubMed ID: 29661157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia.
    Merlino J; Watson J; Rose B; Beard-Pegler M; Gottlieb T; Bradbury R; Harbour C
    J Antimicrob Chemother; 2002 May; 49(5):793-801. PubMed ID: 12003973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibacterial effects of vulgarone B from Artemisia iwayomogi alone and in combination with oxacillin.
    Chung EY; Byun YH; Shin EJ; Chung HS; Lee YH; Shin S
    Arch Pharm Res; 2009 Dec; 32(12):1711-9. PubMed ID: 20162399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
    Shelburne SA; Musher DM; Hulten K; Ceasar H; Lu MY; Bhaila I; Hamill RJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4016-9. PubMed ID: 15388469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
    Maggiolo F; Capra R; Bottura P; Pravettoni G; Migliorino M; Suter F
    J Chemother; 2000 Jun; 12(3):195-8. PubMed ID: 10877512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.